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Purpose/Objective: Radiosurgery is nowadays a valid 
treatment option for patients with brain metastasis. In the 
last year the use of new drugs increases the life expectance 
of these patients and advances in oncologic technology allows 
accurate radiotherapy treatment with high dose delivery and 
sparing of normal tissue resulting in a higher disease control.  
We retrospectively analyzed the efficacy in patients who 
received GammaKnife radiosurgery (GKRS) at our institution. 
Materials and Methods: Between October 2012 and July 
2014, 187 brain metastases in 77 patients were treated with 
Gamma Knife single-fraction RS. Clinical demographic 
features and treatment data were collected.The rates of 
local and distant intracranial progression, predictors of 
individual tumor local control and overall survival were 
determined by statistical analysis. 
Results: The mean age was 63 years (range: 25-87 years). 
The most common tumor histologies were non-small cell lung 
cancer (44 %), breast cancer (16 %) and melanoma (10 %) . 
Forty patients (52%) had a single metastasis, eight patients 
had more than 4 metastases with a maximum of eleven 
lesions in one patient. The most part of patients (62%) were 
in RPA class II and 38 % in RPA class I. Fifteen patients (20%) 
received a previous treatment for brain metastases: five 
patients surgical resection, eight whole brain radiotherapy, 
and two received both surgery and whole brain. Radiosurgery 
doses ranged between 15 Gy for lesions in critical site such as 
brainstem and 24 Gy for lesions with dimension less than 1 
cm. Median survival after GKRS was 13.4 months (range: 0.2-
22.6 months). Median time to local progression was 5.6 
months (range: 0.2-22.6 months), with a local control rate of 
76.6% at 1 year. Distant brain control was 74% at one year. At 
univariate analysis we found that age older than 60 years 
correlate with worse local control compared to youngest 
patients but the difference was not statistically significant 
(p=0.07). Patients with more than four lesions treated had a 
significant higher risk of local relapse (p=0.0003), but this 
data was possibly related to a selection bias. No patients 
developed a symptomatic radiation-induced treatment 
change on follow up MRIs. 
Conclusions: GKRS appears to be a safe and an effective 
technique to treat single and multiple brain metastases. 
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Purpose/Objective: Not much is known about the natural 
history culminating in hemoptysis caused by aspergilloma 
(fungus ball) which colonizes caves of pulmonary tuberculosis 
previously acquired. Local treatment requires surgical 
resection in symptomatic cases, but in patients with surgical 
contraindications, radiotherapy has the potential to be 
effective, and less invasive. 
Materials and Methods: Twenty-one patients with chronic 
necrotizing pulmonary aspergillosis were treated with 
conventional external-beam radiotherapy with a dose of 20 
Gray, from 1990 to 2002. It is initially evaluated the time for 
the development of hemoptysis from the previous treatment 
of tuberculosis. Other outcomes were: change in 
performance status after 30 days of treatment, local failure-
free survival and overall survival. 
Results: The median time between the end of tuberculosis 
treatment and the development of hemoptysis due to 
aspergilloma was 9 years. With radiotherapy, there was 
general improvement and resolution of hemoptysis in all 
patients. During follow-up 4 failures occurred, with local 
failure-free survival of 82% at 5 years and overall survival of 
59% at 5 years. Two patients died from recurrence of 
hemoptysis and two were rescued (cavernostomy and re-
irradiation with 20 Gy). Presence of chronic obstructive 
pulmonary disease (p = 0.021) and female gender (p = 0.032) 
were significantly detrimental in relation to overall survival. 
No variable tested was related to local control. 
Conclusions: Radiation therapy can be considered an 
effective alternative therapy to control bleeding due to 
fungus ball can impact on disease-free survival. 
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Purpose/Objective: Radiation-induced alopecia in 
hypofractionated whole brain radiation therapy with 
simultaneous integrated boost (WBRT+SIB) is an understudied 
issue, even in RTOG 9508. However, this effect has a 
significant impact on the quality of life of patients. We have 
currently found a technical solution to this problem. Our 
current protocol for WBRT+SIB is presented and described, 
incluiding a retrospective review of the results in relation to 
radiation-induced alopecia. 
Materials and Methods: The protocol already implemented in 
our department is based on a frame-less procedure 
compatible with masks of type 35764/2MA/M (Orfit Industries 
N.V., Wijnegem, Belgium), submasks of eXaSkin (Anatomical 
Geometry S.L., Sevilla, Spain) and a resonance compatible 
frame eXaFrame (Anatomical Geometry S.L., Sevilla, Spain).  
CT and MR studies of 1mm slice thickness are acquired with 
similar length, position and inmovilization. The whole 
procedure and the resulting high quality fussion is ensured by 
the eXaFrame system. Treatments were designed using VMAT 
in Treatment System Planning Pinnacle V.9.2 (Philips N.V, 
Koninklijke Holland) with multiple arcs, and delivered with a 
linear accelerator Elekta Synergy (Elekta A.B., Stockholm, 
Sweden). The dose scheme used is the one reported by 
Lagerwaard: [WBRT(20Gy) + SIBmts (40Gy)]/5 fr. Patient 
positioning is verified daily using IGRT with Elekta XVI, before 
and after treatment. Before optimization is performed, some 
auxiliary volumes are created: a 3mm ring around 
calota,called Follicles, and a volume contracted 12mm from 
the outer one, called CPE. Two CCW VMAT arcs (178º to 60º 
and 300º to 182º) are added, with the following objectives: 
Follicles (EQD2max = 16 Gy, weight = 20; EQD2max = 5 Gy, 
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weight = 1), brain-CPE (Dmax = 21 Gy, weight = 100 and Dmin 
= 20 Gy, weight = 50), eyes(Dmax = 10 Gy, weight = 1).  
Thereafter, we work separately on the metastases blocking 
the optimization of the prophylaxis and creating three 
structures: VI1 = PTV (MTS1)+ 5 mm, VI2 = PTV (MTS2)+ 5 
mm, Epx = brain-VI1-VI2. Objectives were: PTVI (Dmax = 44 
Gy, weight = 100 and Dmin = 40 Gy weight = 50), Epx (Dmax = 
30 Gy) ,brain stem (Dmax = 23 Gy) and Follicles (EQD2max = 
16 Gy, weight = 20; EQD2max = 5 Gy,  weight = 20). 
Results: We have treated 14 patients until now. Fusion 
images have shown differences less than 1mm while mean 
IGRT correction has been 1.34mm. No acute toxicity have 
been observed, including neither alopecia nor temporal 
depilation. 
Conclusions: This protocol has been designed and developed 
in our hospital, considering the alopecia as toxicity in VMAT 
optimization. It produces excellent cosmetic results, avoiding 
alopecia in practically all cases, which has a direct impact on 
patient quality of life. As a general consideration, we would 
like to point out that that it should be considered mandatory 
to use all advanced tools available on modern radiotherapy to 
minimize toxicity in radiation treatments. 
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Purpose/Objective: Profit organizations (PO) funding plays 
an important role in research development. Most of these 
sponsorships eventually targets to fund drugs, or industry 
based research. PO may also comprise some level of  conflict 
of interest (COI). We aim to assess and test any association 
between study conclusions and self-reported COI or trial 
sponsorship in breast cancer irradiation. 
Materials and Methods : We searched PubMed for all clinical 
trials (CTs) published between 09/2004 and 09/2014 in breast 
neoplasm (Mesh). All articles published in this period were 
manually screened for eligibility. We included only 
radiotherapy CTs with clinical endpoints. Two investigators 
independently selected phase 2 and 3 CTs with at least 50 
patients published in English and related to radiotherapy. We 
classified eligible trials according to the type of intervention, 
funding source, presence or absence of conflict of interest, 
study conclusion and region/period of publication. 
Results: We retrieved 1,603 CTs of which seventy-six (4.7%) 
were selected. Seventy-two RCTs (4.4% of all CTs) were 
eligible. For - PO, not-for-profit organization (nPO) 
(association or foundation), none and not reported 
sponsorship rates were 12.5%, 48.6%, 1.4%, 37.5%, 
respectively. Positive COI were reported in 8.3% of CTs and 
were negative or not reported in 59.7% and 32%, 
respectively. Eleven journals were responsible for all 
publications, the 'International Journal of Radiation Oncology 
Physics Biology' and the 'Radiotherapy and Oncology' being 
responsible for 55.5% of the publications. Americans were 
committed with 68.2% of sponsorship (profit and non-profit) 
and also reported 66.6% of positive COI. There was no 
significant association between study conclusion (positive or 
negative) and funding source (funded versus no 
funding; P=0.569). However, positive COI were associated 
with positive conclusion (P=0.0001). When comparing high 
impact journal (factor of impact ≥ 4.0 and low < 4.0) and low 
impact journal we found no association with positive 
conclusion (p=0.182), nevertheless 76.4% of the CTs were 
published in high impact factors. There was no association 
between region and sponsorship (p=0.45). 
Conclusions: In this 10-year analysis, PO association played 
the major role in radiotherapy breast funding. No significant 
association between study conclusion (positive or negative) 
and funding source was noticed. Nevertheless self-reported 
COI were associated with positive conclusions. 
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Purpose/Objective: In this work 4 multichannel radiochromic 
film dosimetry calibration procedures are compared. They 
are based on the following bibliography and we will name 
them as: 1)Micke[1], 2)Mayer[2],3)Mendez[3] and 4)the ratio 
between the red and the blue channel[2]. All these methods 
(except nº 4) use enhanced dosimetry procedures which allow 
the separation and removal of the dose-independent part of 
the scanned signal. These procedures introduce channel-
independent perturbations to finally obtain the absorbed 
dose without the spurious scanned signal. 
[1] Micke. M.Phys. 11. 
[2] Mayer. M.Phys. 12. 
[3] Mendez. M.Phys. 14. 
Materials and Methods: To compare the procedures, 10 IMRT 
fields were irradiated. Film dose distributions (using EBT3 
radiochromic film) were compared with their respective 
planned dose distributions (TPS) obtained with XiO and with 
their measured dose distributions using a 2D Array. A γ-index 
analysis was used to compare the distributions. The 
complexity of the procedures was assessed as well. 
To implement all these procedures cited previously, image 
registration tools were used, e.g. to register the planned 
distribution and the measured film image of a wedge field to 
perform the film calibration in the Mendez method, and 
MULTISTART optimization tools also to obtain the 
perturbation parameters introduced by Mendez[3]. 
Results: All the methods obtained very good results (100% of 
points passed the γ criteria when used 3 or even 2 mm, 
regardless of the dose difference %). This demonstrated the 
methods work well and the implementation is correct. 
Therefore a new γ comparison (1%-1mm) was made to 
appreciate some differences. The Micke and Mayer methods, 
